Jarrow Formulas has added a high-potency pterostilbene supplement to its product line, made with ChromaDex’s (Irvine, CA) pTeroPure trans-pterostilbene.
Jarrow Formulas has added a high-potency pterostilbene supplement to its product line, made with ChromaDex’s (Irvine, CA) pTeroPure trans-pterostilbene. The product is aimed to support healthy aging.
According to Jarrow:
“Pterostilbene is found naturally in blueberries, grapes and the bark of the Indian Kino Tree (Pterocarpus marsuplum). Also called dimethylresveratrol, it is a member of the class of nutrients known as stilbenes, which also includes resveratrol. In comparison with resveratrol, pterostilbene is both more stable and more active, exhibiting greater bioavailability. Pterostilbene has demonstrated positive results in areas such as cardiovascular and brain health. Research suggests pterostilbene may mimic many of the benefits of calorie-restricted diets by activating the sirtuin pathway associated with longevity.
The pterostilbene source used by Jarrow Formulas is the subject of several ongoing scientific trials. These include clinical research being conducted at the University of Mississippi Medical Center in connection with the plant compound’s effects with regard to cholesterol, blood pressure, inflammatory responses and oxidative stress.”
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.